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Cell-free protein synthesis (CFPS) is emerging as a robust 
platform for fundamental and applied research in the 
areas of synthetic biology and biotechnology [1, 2]. CFPS 
has been developed with several different organisms (e.g. 
E. coli, wheat germ, rabbit reticulocytes, CHO cells, yeast, 
and insect cells) to produce various proteins including 
therapeutic vaccines, virus-like particles, and membrane 
proteins [3–26]. CFPS is also being used for high-through-
put functional and structural studies of a wide variety of 
proteins [27, 28], as well as more recently for rapid proto-
typing of biological circuits [29–35]. Although different 
CFPS systems have their own advantages, the E. coli-
based system is the most commonly used due to fast cell 
growth of the source strain, inexpensive and streamlined 
extract preparation, and generally high protein yields. 
Because of the absence of cell walls in cell-free systems, 
cofactors (e.g. metal ions) and substrates are easily added 
to the reaction and the expression environment is highly 
controlled. This enables the production of fully active 
complex biocatalysts. The E. coli-based platform has 
successfully been used to produce enzymes with metal 
cofactors such as [FeFe] hydrogenases [36–40] and P450 
monooxygenase [41]. Using multicopper oxidases as a 
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model, we investigated the use of cell-free biosynthesis 
to produce copper enzymes.
Multicopper oxidases (MCOs) are a well-characterized 
group of enzymes that couple the reduction of dioxygen 
to water with the oxidation of a broad range of substrates 
[42]. Because of their broad activity, they have attracted 
signiﬁcant attention for use in a variety of biotechno-
logical applications including wastewater decolorization, 
pulp deligniﬁcation, and enzymatic fuel cells [43]. Native-
ly, MCOs are found in all kingdoms of life and are known 
to function in plant development, metal homeostasis, 
and fungal deligniﬁcation [44]. To perform their function, 
MCOs require four copper atoms arranged in two dis-
tinct metal centers, a mononuclear type 1 copper and a 
trinuclear copper cluster formed by a type 2 copper and a 
pair of type 3 coppers [45]. Substrates are oxidized at the 
type 1 copper center and electrons are then transferred 
to the trinuclear copper cluster where oxygen is reduced 
to water [45].
MCOs were chosen for this study because their 
reported in vivo expression yields tend to be low and cop-
per incorporation can be challenging [46]. In the present 
work, two bacterial MCOs from Nitrosomonas europaea 
(NeMCO) and Streptomyces coelicolor (ScMCO) and two 
archaeal MCOs from Haloarcula marismortui (HmMCO) 
and Nitrosopumilus maritimus (NmMCO) were synthe-
sized. Using the E. coli CFPS platform, three of the four 
MCOs had ﬁnal yields of more than 1 mg mL-1. Signiﬁ-
cant amounts of copper (100 μM) can be present during 
synthesis without impacting expression levels; however, 
given the high expression levels of the MCO this is not 
sufﬁcient to completely metal load the protein. We found 
that CuSO4 stimulates MCO activity by post-translational 
addition after CFPS. To the best of our knowledge, this is 
the ﬁrst report on cell-free synthesis of an active MCO in 
the E. coli-based system. Our results, therefore, expand 
the ever-growing utility of CFPS techniques to include 
the production of MCOs and proteins with copper cofac-
tors.
2 Materials and methods
2.1 Bacterial strains and plasmids
Highly active S30 crude extracts were generated from 
a genomically recoded release factor 1 (RF1) deﬁcient 
E. coli strain (E. coli C321.ΔA.705) [47]. Multicopper 
oxidase genes from Haloarcula marismortui (HmMCO, 
accession no. WP_004594571), Nitrosopumilus maritimus 
(NmMCO, accession no. WP_012215737) and Strepto-
myces coelicolor (ScMCO, accession no. WP_003972284) 
were codon optimized with E. coli class 2 codons, native 
secretion signals were omitted, and synthesized as 
gBlocks® (IDT Inc., Coralville, IA, USA). The Nitrosomonas 
europaea gene (NeMCO accession no. WP_011111538) 
was not codon optimized, but it was also synthesized 
using gBlocks®. The gBlocks® were incorporated into 
the vector pY71 using Gibson Assembly [48] and the 
DNA sequence veriﬁed (Euroﬁns Genomics, Huntsville, 
AL, USA). The four MCO genes were cloned in frame 
with a C-terminal tag comprised sequentially of a TEV 
cleavage site, (Gly3Ser)2 linker, ?-strand 11 of GFP [49], a 
Gly3Ser linker and a Strep-tag. The GFP11 sequence was 
inserted before the Strep-tag to facilitate a future study 
for high-throughput screening soluble expression of MCO 
variants. The following plasmids were tested in in vitro 
CFPS assays: pY71-NeMCO-TGS, pY71-HmMCO-TGS, 
pY71-NmMCO-TGS and pY71-ScMCO-TGS.
2.2 Preparation of cell extracts
E. coli cells were grown in 1 L of 2xYTPG (yeast extract 
10 g L-1, tryptone 16 g L-1, NaCl 5 g L-1, K2HPO4 7 g L
-1, 
KH2PO4 3 g L
-1 and glucose 18 g L-1, pH 7.2) in a 2.5-L Tun-
air ﬂask (IBI Scientiﬁc, Peosta, IA) at 34°C and 220 rpm 
with inoculation of 20 mL overnight cultures (initial OD600 
of ~0.05). Cell growth, collection and extracts were pre-
pared as described by Kwon and Jewett [50].
2.3 CFPS reactions
Standard CFPS reactions were performed using the 
 PANOx-SP system as previously described [51]. For cop-
per loading, CuSO4 was added to the standard system with 
ﬁnal concentrations of 10, 20, 50, 100, 200 and 500 μM. For 
scale-up reactions with 50 and 100 μL mixture, the reac-
tions were carried out in 2 mL microcentrifuge tubes. All 
CFPS reactions were incubated for 20 h at 30°C.
2.4 Quantiﬁcation of synthesized MCOs
The yields of synthesized MCOs were quantiﬁed by the 
incorporation of 14C-leucine into trichloroacetic acid-pre-
cipitable radioactivity using a liquid scintillation counter 
(MicroBeta2, PerkinElmer, Waltham, MA) as described 
previously [52]. Total protein yields were measured direct-
ly after cell-free reactions with the 15  μL mixture. To 
determine the soluble protein yield, 15 μL of the reaction 
mixture was centrifuged at 12 000 ×g and 4°C for 15 min 
[53]. 10 μL of the supernatant were taken out for soluble 
MCO quantiﬁcation.
2.5 Autoradiography analysis
After the cell-free reaction, 3  μL of each sample was 
loaded on a 4–12% NuPAGE SDS-PAGE gel (Invitrogen). 
The gel was stained using SimplyBlueTM SafeStain solu-
tion (Invitrogen) and destained in water. Then, the gel 
was ﬁxed with cellophane ﬁlms (Bio-Rad), dried overnight 
in a GelAir Dryer (Bio-Rad) without heating, and exposed 
for 48  h on a Storage Phosphor Screen (GE Healthcare 
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Biosciences, Pittsburgh, PA). The autoradiogram was 
scanned using a Storm Imager (GE Healthcare Bio-
sciences, Pittsburgh, PA) and analyzed using Quantity 
One software (Bio-Rad, Hercules, CA).
2.6 MCO activity assay
MCO activity was measured colorimetrically by following 
oxidation of ABTS (? = 36.8 mM-1cm-1 at 405 nm), which 
turns blue upon oxidation [54]. Colorimetric assays were 
performed in 1  mL of 100  mM Britton-Robinson buffer 
at pH 4.0 containing 4 mM ABTS using an Agilent 4853 
spectrophotometer. All cell-free reactions were diluted 
10-fold and incubated with 0 to 5  mM CuSO4 or 0 to 
500 μM Cu(CH3CN)4PF6 and at room temperature for 2 h. 
In cases where Cu(CH3CN)4PF6 was added, the reac-
tion was transferred into an anaerobic Coy chamber and 
allowed to equilibrate for 2 h prior to addition of copper. 
All reactions were initiated by addition of 40 to 80 μL of 
diluted cell-free samples and reported values are aver-
aged from at least three replicates. All reactions were 
performed at room temperature.
2.7 In vivo expression of MCOs
MCOs were expressed in E. coli strain BL21(DE3) and 
grown in homemade autoinduction media [55]. Cells were 
grown at 37°C to an OD600 of ~0.6 and then moved to 20°C 
for 16 h. Prior to harvest cells were incubated with 5 mM 
CuSO4 for 2 h and then centrifuged for 10 min at 6 400 ×g 
and 4°C. Cells were suspended in 50 mM TRIS pH 8.0 and 
500 mM NaCl and lysed by sonication for 8 min with 1 s 
pulses and 3 s resting time. Lysates were centrifuged for 
1 h at 185 000 ×g and 4°C and the supernatants applied 
to a streptactin column (IBA Life Sciences). MCOs were 
eluted with 50 mM TRIS pH 8.0, 500 mM NaCl, and 5 mM 
d-desthiobiotin and then concentrated in Amicon cen-
trifugal devices with a 30 kDa nominal molecular weight 
cutoff (EMD Millipore). The concentrated MCOs were 
then further puriﬁed on a Superdex 200 Increase (GE 
Healthcare Life Sciences) size exclusion column equili-
brated with 50 mM TRIS pH 8.0 and 500 mM NaCl. Final 
yields of the MCOs were determined using their extinc-
tion coefﬁcients at 280 nm.
3 Results and discussion
3.1  CFPS enables soluble high-level expression  
of four MCOs
The E. coli-based cell-free system used in this work is 
similar to a previously published report [51], with only 
minor modiﬁcations (see above). The reactions were 
allowed to run for 20 h in batch operation and the yields 
of cell-free synthesized MCOs were quantiﬁed by moni-
toring 14C-leucine incorporation. As shown in Fig.  1A, 
the best expressing variant, NeMCO, gave a protein 
yield of 1.2 ± 0.1 mg mL-1 (>95% soluble), while ScMCO 
yields reached less than 0.2  mg  mL-1. HmMCO and 
NmMCO also reached high ﬁnal yields of ~1  mg  mL-1; 
however, their soluble fractions were lower than NeMCO, 
constituting 36 and 70% of the total protein expression, 
respectively. These yields are higher than those typically 
Figure 1. Cell-free protein synthesis of two bacterial and two archaeal MCOs. (A) Protein yields of MCOs. T, total protein; S, soluble protein. Error bars 
represent standard deviations from three independent samples.(B) SDS-PAGE analysis of cell-free produced MCOs. Each MCO is indicated by an asterisk. 
Expected molecular weight: NeMCO (41.1 kDa), HmMCO (43.5 kDa), NmMCO (51.6 kDa), ScMCO (39.4 kDa). M, protein molecular weight marker; NC, 
negative control without plasmid in the reaction. (C) Autoradiogram of radioactive labeled proteins.
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observed in vivo. For example, the expression levels of lac-
cases (belonging to the MCO family) from Bacillus subtilis 
and Aeromonas hydrophila in E. coli are ~20 mg L-1 and 
~10 mg L-1, respectively [56, 57]. The fact that different 
MCOs from different organisms expressed at different 
titers was not surprising, as expression levels are known 
to be highly dependent on several gene sequence fea-
tures, such as the position dependent codon usage, ribo-
some binding site, mRNA structure, etc. [58]. Even with 
different titers, expressed MCOs could be identiﬁed from 
the E. coli endogenous proteins using SDS-PAGE gels. 
These results show that the correct molecular weights 
were obtained (Fig.  1B) and were further conﬁrmed by 
autoradiogram analysis (Fig. 1C). Because NeMCO pro-
duced the highest soluble yields, subsequent analysis 
focused on it as a target.
To directly compare our CFPS expression system 
to conventional in vivo strategies, the four MCO con-
structs were also expressed in living E. coli (Table 1). In 
vivo expression yields for all constructs were less than 
50  mg  L-1, which is lower than that obtained with the 
E. coli-based CFPS system. Notably, two of the constructs, 
HmMCO and NmMCO, form only inclusion bodies in 
vivo, whereas they are soluble in vitro. This highlights a 
potential advantage for CFPS. We believe the increased 
solubility in vitro may arise from the dilute total protein 
environment in the extract (~10 mg mL-1 total E. coli pro-
tein) as compared to the cytoplasm (~200–300 mg mL-1 
total E. coli protein), which helps favor protein folding 
over aggregation.
3.2  Effect of scalability and copper concentration 
on CFPS yields of NeMCO
To demonstrate the potential application of CFPS of 
MCOs, the reaction volume of NeMCO was scaled from 15 
to 100 μL. While the reaction volume increased more than 
six times compared to the standard reaction, NeMCO 
expression levels were similar to small scale reactions 
with total yields of ~1.2 mg mL-1 (Fig. 2A). Importantly, 
approximately 95% of the expressed protein remained 
soluble.
Copper is necessary for reconstitution of the MCO’s 
activity. To this end, the effect of copper concentration 
Table 1. Examples of MCOs heterologously expressed in vivo
MCOa) Source Expression host Titer (mg L-1) Reference
NeMCO Nitrosomonas europaea E. coli 42.0 ± 14b) This Study
HmMCO Haloarcula marismortui E. coli Inclusion bodiesb) This Study
NmMCO Nitrosopumilus maritimus E. coli Inclusion bodiesb) This Study
ScMCO Streptomyces coelicolor E. coli 11.0 ± 4.1b) This Study
Laccase Bacillus subtilis E. coli 20 [56]
Laccase Aeromonas hydrophila E. coli 10 [57]
Laccase Streptomyces coelicolor Streptomyces lividans 350 [63]
Laccase Myceliophthora thermophila Saccharomyces cerevisiae 18 [64]
Laccase Schizophyllum commune Pycnoporus cinnabarinus 1200 [65]
a) Laccase belongs to the multicopper oxidase family (MCO).
b)  Yield after metal loading and growth in autoinduction media. In all cases signiﬁcant quantities of inclusion bodies were observed in addition to the reported 
 soluble expression yields.
Figure 2. (A) Cell-free protein synthesis of NeMCO with scale-up systems. 
T, total NeMCO; S, soluble NeMCO. (B) Effect of Cu2+ on NeMCO synthe-
sis in the cell-free system. Error bars represent standard deviations from 
three independent samples.
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on expression levels was studied using NeMCO as copper 
is toxic for many bacteria. At moderate concentrations, 
0 to 100 μM, there is no obvious decrease in protein yield 
(Fig.  2B), suggesting some beneﬁts for CFPS avoiding 
toxicity that occurs in cells. However, at high concentra-
tions of copper, 200 μM and above, expression drops sig-
niﬁcantly and copper appears to be toxic to the combined 
transcription-translation system. Consistent with the 
hypothesis that copper may be toxic to CFPS, we found 
that copper concentrations of 100 μM reduced expression 
of superfolder green ﬂuorescent protein (which does not 
have copper cofactors) four-fold as compared to reactions 
without supplemented copper (data not shown). Our 
results suggest that copper appears to be toxic to CFPS 
at high concentrations, but less toxic when manufactur-
ing copper-containing proteins, which likely sequester 
the copper.
3.3  Cell-free synthesized NeMCO is active,  
and stimulated by post-translational  
copper addition
To verify that the cell-free synthesized NeMCO was 
active, assays were performed by following the oxida-
tion of 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic 
acid) (ABTS), a non-native substrate, which is blue in 
its oxidized form. Initially these experiments focused on 
NeMCO that was synthesized in the presence of 100 μM 
copper. Our results indicate that synthesis in 100  μM 
copper is not sufﬁcient to obtain active protein but post-
translational addition of CuSO4 stimulates activity (Fig. 3). 
In cell-free reactions the ﬁnal concentration of NeMCO is 
~30 μM and each monomer requires at least four coppers. 
It is therefore not unexpected that NeMCO is not active 
immediately following the cell-free reaction since there 
is not enough copper in solution to fully load the enzyme. 
To test if post-translational addition of copper stimulates 
activity, reactions were diluted and Cu(II) in the form of 
CuSO4 was added (Fig. 3). Our data show that activity is 
stimulated by relatively low concentrations of copper and 
is diminished if too much copper is added. Diminished 
activity is likely due to protein precipitation caused by 
excess copper ions. Importantly, we do not observe cop-
per acting as a catalyst alone to oxidize the substrate. 
Negative controls with similarly prepared CFPS reactions 
without plasmids were performed with and without cop-
per and oxidation of the dye was not observed.
Previous reports suggest that maximal activity of 
MCOs is obtained when copper is loaded as Cu(I) [56]. 
To test this possibility, cell-free reactions were taken into 
an anaerobic Coy chamber and incubated with a Cu(I) 
compound, Cu(CH3CN)4PF6, in a similar fashion as the 
CuSO4 experiments. These data show that incubating 
with Cu(I) versus Cu(II) results in similar levels of activity. 
Cu(I) could not be tested at concentrations above 500 μM 
because at these concentrations direct reduction of ABTS 
by unbound Cu(I) is observed preventing reliable data 
collection. Unfortunately, the current speciﬁc activity of 
NeMCO is ~10% the rate of the same protein produced 
in vivo lacking a C-terminal tag [59]. We attribute this 
diminished rate to the large C-terminally encoded tag, 
which has been previously shown to greatly reduce MCO 
activity [60]. Indeed, the lower speciﬁc activity in the 
CFPS system matches the activity of in vivo expressed 
NeMCO in E. coli with the same C-terminal tag (data not 
shown). Thus, our work provides a promising route to 
discovery-based applications that require rapid, low-cost 
protein expression, such as high-throughput screening of 
soluble MCO variants.
4  Concluding remarks: CFPS offers  
a new approach for producing MCOs  
at high titers
In conclusion, multiple MCOs were expressed in an 
E. coli-based CFPS system with high yields (>1 mg mL-1). 
Scale-up reactions were achieved from 15 to 100 μL with-
out decreasing productivity and solubility. Importantly, 
MCO activity can be obtained by simple addition of cop-
per ions post-translation and our work also establishes a 
threshold for copper tolerance in E. coli-based CFPS. Our 
work is important because it allows for expression levels 
that are adequate for testing MCO activity, setting the 
stage for a high-throughput expression platform that can 
be executed in a day through the use of PCR templates, 
as compared to days to weeks in vivo [6].
Indeed, our approach may provide some potential 
advantages for high yielding expression in high-through-
put as compared to existing state of the art. As sum-
marized in the review paper [61], different heterologous 
Figure 3. Effect of copper concentration on speciﬁc activity. White, no 
additional copper added; light gray, addition of Cu(I) as Cu(CH3CN)4PF6; 
dark gray, addition of Cu(II) as CuSO4. Error bars represent standard devi-
ations from three independent samples.
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hosts have been used to express MCOs (mostly laccases) 
including bacteria systems (e.g. E. coli and Streptomyces 
lividans), yeast systems (e.g. Saccharomyces cerevisiae, 
Pichia pastoris, etc.), and ﬁlamentous fungi systems (e.g. 
Aspergillus niger, Trichoderma reesei, etc.). Previous 
expression titers are typically lower than those observed 
here (~10–50 mg L-1). A summary of these results, includ-
ing the in vivo expression of the constructs expressed in 
vitro in this study, can be found in Table 1.
Looking forward, opportunities to improve the CFPS 
system include gaining a better understanding of the cop-
per loading conditions, enabling efﬁcient glycosylation 
that is required for some archaeal enzymes [62], and dem-
onstrating higher preparative reaction scales of active 
MCOs. However, we note that the E. coli CFPS system 
has already been shown to scale linearly from μL reactions 
to the 100 L scale, an expansion factor of 106, to enable 
manufacturing scale synthesis of complex proteins [26]. 
We therefore anticipate that CFPS systems will provide a 
new avenue for producing MCOs in the future.
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